Amgen K.K
Amgen is committed to unlocking the potential of biology for patients suffering from serious illnesses by discovering, developing, manufacturing and delivering innovative human therapeutics. This approach begins by using tools like advanced human genetics to unravel the complexities of disease and understand the fundamentals of human biology.
See below for the Latest Amgen K.K News, Analysis, Profit Results, Share Price Information, and Commentary.
Amgen migraine advocacy project wins trophy at the Healthcare Asia Pharma Awards
An online seminar gathered specialists, influencers, journalists, patients, and caregivers toend the stigma surrounding migraine.
Amgen migraine advocacy project wins trophy at the Healthcare Asia Pharma Awards
An online seminar gathered specialists, influencers, journalists, patients, and caregivers toend the stigma surrounding migraine.
Most Read
1. SGH and NNI study reveals connection between scoliosis and brainstem 2. Why rare disease policies are critical to ensure equitable access to treatment for rare disease communities in Southeast Asia 3. 3 in 5 novice nurses struggle with higher-complexity procedures 4. EGH Campus in Bedok North to offer services before 2030 completion 5. Around 4 in 5 healthcare organistation plan IT modernisationResource Center
Read Here
Advertise
Sign Up
Event News
Event News
Discover cutting-edge strategies reshaping healthcare delivery with EY’s Abhay Bangi
![Discover cutting-edge strategies reshaping healthcare delivery with EY’s Abhay Bangi]()
Co-Written / Partner
Explore the complexities of the healthcare landscape, as well as innovation and transformation within the sector, guided by the EY expert’s visionary insights.
Explore the complexities of the healthcare landscape, as well as innovation and transformation within the sector, guided by the EY expert’s visionary insights.
